Merge
Ncbi
Racine
Merge
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Viral Infections

Identifieur interne : 002D51 ( Ncbi/Merge ); précédent : 002D50; suivant : 002D52

Viral Infections

Auteurs :

Source :

RBID : PMC:7122910

Abstract

Despite major advances in basic and applied research and the availability of several vaccines, viral diseases still account for a large proportion of the human infectious disease burden. Many viruses cause self-limiting and relatively mild infections, but several, including human immunodeficiency virus and influenza virus, are responsible for millions of deaths every year throughout the world. Several factors contribute to the enormous impact that viruses have on human health. For example, there are very few therapeutic options available for the treatment of viral infections, and many of those that are available possess a limited spectrum of activity or are designed for the treatment of diseases caused by specific viruses (e.g., oseltamivir is intended for the treatment of influenza only). In addition, the rapid evolution of viruses has led to the emergence of drug-resistant strains against which no currently available therapeutics are effective. Coupled with these and other issues are the appearance of never before seen viruses and the emergence of known but previously underappreciated viruses. Since the beginning of the twenty-first century, numerous “new” viruses, including the coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), the 2009 pandemic influenza A virus, and Lujo hemorrhagic fever virus, have made their debut and have proved to be formidable threats to human health. Recently, the appearance of Ebola virus (Zaire ebolavirus) in West Africa, a region that has not previously seen an outbreak of this virus, was marked by an epidemic that afflicted nearly 30,000 individuals and killed more than 11,000 of those who were infected. Most recently, the far-reaching and rapid spread of Zika virus, a mosquito-borne virus that was discovered in the 1940s in Uganda, in the Western Hemisphere has invoked considerable public and scientific attention and has given rise to perhaps the largest concerted effort by scientists to rapidly develop a vaccine to halt the transmission of a virus. Each of these points underscores the importance of further research into improved surveillance, diagnosis, treatment, and prevention of viral diseases.


Url:
DOI: 10.1007/978-3-319-54702-2_3
PubMed: NONE
PubMed Central: 7122910

Links toward previous steps (curation, corpus...)

Links to Exploration step

PMC:7122910

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Viral Infections</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">7122910</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122910</idno>
<idno type="RBID">PMC:7122910</idno>
<idno type="doi">10.1007/978-3-319-54702-2_3</idno>
<idno type="pmid">NONE</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000215</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000215</idno>
<idno type="wicri:Area/Pmc/Curation">000215</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000215</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000676</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000676</idno>
<idno type="wicri:Area/Ncbi/Merge">002D51</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Viral Infections</title>
</analytic>
<series>
<title level="j">Atlas of Infectious Disease Pathology </title>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="Par1">Despite major advances in basic and applied research and the availability of several vaccines, viral diseases still account for a large proportion of the human infectious disease burden. Many viruses cause self-limiting and relatively mild infections, but several, including human immunodeficiency virus and influenza virus, are responsible for millions of deaths every year throughout the world. Several factors contribute to the enormous impact that viruses have on human health. For example, there are very few therapeutic options available for the treatment of viral infections, and many of those that are available possess a limited spectrum of activity or are designed for the treatment of diseases caused by specific viruses (e.g., oseltamivir is intended for the treatment of influenza only). In addition, the rapid evolution of viruses has led to the emergence of drug-resistant strains against which no currently available therapeutics are effective. Coupled with these and other issues are the appearance of never before seen viruses and the emergence of known but previously underappreciated viruses. Since the beginning of the twenty-first century, numerous “new” viruses, including the coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), the 2009 pandemic influenza A virus, and Lujo hemorrhagic fever virus, have made their debut and have proved to be formidable threats to human health. Recently, the appearance of Ebola virus (
<italic>Zaire ebolavirus</italic>
) in West Africa, a region that has not previously seen an outbreak of this virus, was marked by an epidemic that afflicted nearly 30,000 individuals and killed more than 11,000 of those who were infected. Most recently, the far-reaching and rapid spread of Zika virus, a mosquito-borne virus that was discovered in the 1940s in Uganda, in the Western Hemisphere has invoked considerable public and scientific attention and has given rise to perhaps the largest concerted effort by scientists to rapidly develop a vaccine to halt the transmission of a virus. Each of these points underscores the importance of further research into improved surveillance, diagnosis, treatment, and prevention of viral diseases.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Brackney, De" uniqKey="Brackney D">DE Brackney</name>
</author>
<author>
<name sortKey="Armstrong, Pm" uniqKey="Armstrong P">PM Armstrong</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burke, Ds" uniqKey="Burke D">DS Burke</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dash, Ap" uniqKey="Dash A">AP Dash</name>
</author>
<author>
<name sortKey="Bhatia, R" uniqKey="Bhatia R">R Bhatia</name>
</author>
<author>
<name sortKey="Sunyoto, T" uniqKey="Sunyoto T">T Sunyoto</name>
</author>
<author>
<name sortKey="Mourya, Dt" uniqKey="Mourya D">DT Mourya</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Feldmann, H" uniqKey="Feldmann H">H Feldmann</name>
</author>
<author>
<name sortKey="Geisbert, Tw" uniqKey="Geisbert T">TW Geisbert</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Goldsmith, Cs" uniqKey="Goldsmith C">CS Goldsmith</name>
</author>
<author>
<name sortKey="Whistler, T" uniqKey="Whistler T">T Whistler</name>
</author>
<author>
<name sortKey="Rollin, Pe" uniqKey="Rollin P">PE Rollin</name>
</author>
<author>
<name sortKey="Ksiazek, Tg" uniqKey="Ksiazek T">TG Ksiazek</name>
</author>
<author>
<name sortKey="Rota, Pa" uniqKey="Rota P">PA Rota</name>
</author>
<author>
<name sortKey="Bellini, Wj" uniqKey="Bellini W">WJ Bellini</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Goldsmith, Cs" uniqKey="Goldsmith C">CS Goldsmith</name>
</author>
<author>
<name sortKey="Ksiazek, Tg" uniqKey="Ksiazek T">TG Ksiazek</name>
</author>
<author>
<name sortKey="Rollin, Pe" uniqKey="Rollin P">PE Rollin</name>
</author>
<author>
<name sortKey="Comer, Ja" uniqKey="Comer J">JA Comer</name>
</author>
<author>
<name sortKey="Nicholson, Wl" uniqKey="Nicholson W">WL Nicholson</name>
</author>
<author>
<name sortKey="Peret, Tc" uniqKey="Peret T">TC Peret</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jaffe, Hw" uniqKey="Jaffe H">HW Jaffe</name>
</author>
<author>
<name sortKey="Frankel, Ss" uniqKey="Frankel S">SS Frankel</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mayer, Sv" uniqKey="Mayer S">SV Mayer</name>
</author>
<author>
<name sortKey="Tesh, Rb" uniqKey="Tesh R">RB Tesh</name>
</author>
<author>
<name sortKey="Vasilakis, N" uniqKey="Vasilakis N">N Vasilakis</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Molina Ruiz, Am" uniqKey="Molina Ruiz A">AM Molina-Ruiz</name>
</author>
<author>
<name sortKey="Santonja, C" uniqKey="Santonja C">C Santonja</name>
</author>
<author>
<name sortKey="Rutten, A" uniqKey="Rutten A">A Rütten</name>
</author>
<author>
<name sortKey="Cerroni, L" uniqKey="Cerroni L">L Cerroni</name>
</author>
<author>
<name sortKey="Kutzner, H" uniqKey="Kutzner H">H Kutzner</name>
</author>
<author>
<name sortKey="Requena, L" uniqKey="Requena L">L Requena</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Molina Ruiz, Am" uniqKey="Molina Ruiz A">AM Molina-Ruiz</name>
</author>
<author>
<name sortKey="Santonja, C" uniqKey="Santonja C">C Santonja</name>
</author>
<author>
<name sortKey="Rutten, A" uniqKey="Rutten A">A Rütten</name>
</author>
<author>
<name sortKey="Cerroni, L" uniqKey="Cerroni L">L Cerroni</name>
</author>
<author>
<name sortKey="Kutzner, H" uniqKey="Kutzner H">H Kutzner</name>
</author>
<author>
<name sortKey="Requena, L" uniqKey="Requena L">L Requena</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Peters, Cj" uniqKey="Peters C">CJ Peters</name>
</author>
<author>
<name sortKey="Zaki, Sr" uniqKey="Zaki S">SR Zaki</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shibl, A" uniqKey="Shibl A">A Shibl</name>
</author>
<author>
<name sortKey="Senok, A" uniqKey="Senok A">A Senok</name>
</author>
<author>
<name sortKey="Memish, Z" uniqKey="Memish Z">Z Memish</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Solomon, Ih" uniqKey="Solomon I">IH Solomon</name>
</author>
<author>
<name sortKey="Milner, Da" uniqKey="Milner D">DA Milner</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vasilakis, N" uniqKey="Vasilakis N">N Vasilakis</name>
</author>
<author>
<name sortKey="Weaver, Sc" uniqKey="Weaver S">SC Weaver</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zaki, Sr" uniqKey="Zaki S">SR Zaki</name>
</author>
<author>
<name sortKey="Kilmarx, Ph" uniqKey="Kilmarx P">PH Kilmarx</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="chapter-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">978-3-319-54702-2</journal-id>
<journal-id journal-id-type="doi">10.1007/978-3-319-54702-2</journal-id>
<journal-id journal-id-type="nlm-ta">Atlas of Infectious Disease Pathology </journal-id>
<journal-title-group>
<journal-title>Atlas of Infectious Disease Pathology </journal-title>
</journal-title-group>
<isbn publication-format="print">978-3-319-54701-5</isbn>
<isbn publication-format="electronic">978-3-319-54702-2</isbn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmc">7122910</article-id>
<article-id pub-id-type="publisher-id">3</article-id>
<article-id pub-id-type="doi">10.1007/978-3-319-54702-2_3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Viral Infections</article-title>
</title-group>
<contrib-group content-type="book editors">
<contrib contrib-type="editor">
<name>
<surname>Schmitt</surname>
<given-names>Bryan H.</given-names>
</name>
<address>
<email>bhschmit@iupui.edu</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2287 3919</institution-id>
<institution-id institution-id-type="GRID">grid.257413.6</institution-id>
<institution>Department of Pathology and Laboratory Medicine,</institution>
<institution>Indiana University School of Medicine,</institution>
</institution-wrap>
Indianapolis, Indiana USA</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Relich</surname>
<given-names>Ryan F.</given-names>
</name>
<address>
<email>rrelich@iupui.edu</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2287 3919</institution-id>
<institution-id institution-id-type="GRID">grid.257413.6</institution-id>
<institution>Department of Pathology and Laboratory Medicine,</institution>
<institution>Indiana University School of Medicine,</institution>
</institution-wrap>
Indianapolis, IN USA</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>18</day>
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<fpage>75</fpage>
<lpage>100</lpage>
<permissions>
<copyright-statement>© Springer International Publishing AG 2017</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Despite major advances in basic and applied research and the availability of several vaccines, viral diseases still account for a large proportion of the human infectious disease burden. Many viruses cause self-limiting and relatively mild infections, but several, including human immunodeficiency virus and influenza virus, are responsible for millions of deaths every year throughout the world. Several factors contribute to the enormous impact that viruses have on human health. For example, there are very few therapeutic options available for the treatment of viral infections, and many of those that are available possess a limited spectrum of activity or are designed for the treatment of diseases caused by specific viruses (e.g., oseltamivir is intended for the treatment of influenza only). In addition, the rapid evolution of viruses has led to the emergence of drug-resistant strains against which no currently available therapeutics are effective. Coupled with these and other issues are the appearance of never before seen viruses and the emergence of known but previously underappreciated viruses. Since the beginning of the twenty-first century, numerous “new” viruses, including the coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), the 2009 pandemic influenza A virus, and Lujo hemorrhagic fever virus, have made their debut and have proved to be formidable threats to human health. Recently, the appearance of Ebola virus (
<italic>Zaire ebolavirus</italic>
) in West Africa, a region that has not previously seen an outbreak of this virus, was marked by an epidemic that afflicted nearly 30,000 individuals and killed more than 11,000 of those who were infected. Most recently, the far-reaching and rapid spread of Zika virus, a mosquito-borne virus that was discovered in the 1940s in Uganda, in the Western Hemisphere has invoked considerable public and scientific attention and has given rise to perhaps the largest concerted effort by scientists to rapidly develop a vaccine to halt the transmission of a virus. Each of these points underscores the importance of further research into improved surveillance, diagnosis, treatment, and prevention of viral diseases.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Virus</kwd>
<kwd>Inclusion body</kwd>
<kwd>Viral factories</kwd>
<kwd>Syncytium</kwd>
<kwd>Virion</kwd>
<kwd>Cytopathic effect</kwd>
<kwd>Councilman body</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer International Publishing AG 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D51 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002D51 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:7122910
   |texte=   Viral Infections
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021